BRIEF-Sanofi, Regeneron's high cholesterol drug Praluent gets EMA nod By: Reuters: Company News July 24, 2015 at 07:10 AM EDT * EU Medicines Agency recommends approval of high cholesterol drug Praluent from Sanofi SA/Regeneron Pharmaceuticals Read More >> Related Stocks: Banco Santander ADR Merck & Co Regeneron Pharmaceuticals